Antiplatelet therapy of secondary stroke prevention after ESPS-2 and CAPRIE;Antiagregacion plaquetaria en la prevencion secundaria del ictus despues del ESPS-2 y del CAPRIE

Revista de Neurologia

Volumn 29, Issue 8, 1999, Pages 780-784

  Alvarez Sabin J ^a,b   Montaner Villalonga, J ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Vail d'Hebron University Hospital   (Spain)

Author keywords

Antithrombotic therapy; Aspirin; Clopidogrel; Dipyridamole; Secondary stroke prevention; Triflusal

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE; TRIFLUSAL; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; SALICYLIC ACID DERIVATIVE;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; SECONDARY PREVENTION; STROKE; TREATMENT PLANNING; CEREBROVASCULAR ACCIDENT; RECURRENT DISEASE; REVIEW;

CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; DIPYRIDAMOLE; HUMANS; PLATELET AGGREGATION INHIBITORS; RECURRENCE; SALICYLATES; TICLOPIDINE;

EID: 0033621276     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.2908.99176     Document Type: Conference Paper

References (21)

1. Van Gijn J, Algra A. Secondary stroke prevention with antithrombotic drugs: what to do next. Cerebrovasc Dis 1997; 7 (Suppl 6): 30-2.
2. Antiplatelet Trialist's Collaboration. Collaborative overview of randomized trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106.
3. Álvarez Sabín J. Ácido acetilsalicílico y triflusal en la prevención del infarto cerebral aterotrombótico. Rev Neurol 1995; 23: 1091-5.
4. Dyken ML, Barnett HJM, Easton JD, Fields WS, Fuster V, Hachinski V. Low-dose aspirin and stroke. 'It ain't necessarily so'. Stroke 1992; 23: 1395-9.
5. Álvarez Sabín J, Calvo G, Morros R. Prevención secundaria del ictus isquémico. Efecto de la dosis en el perfil de la aspirina. Rev Neurol 1997; 25: 541-4.
6. Álvarez Sabín J, Matías-Guiu J, Galiano L, Codina-Puiggrós A. El riesgo hemorrágico en la toma prolongada de aspirina y triflusal. Rev Neurol 1998; 27: 951-5.
7. Hankey GJ. One year after CAPRIE, IST and ESPS-2. Cerebrovasc Dis 1998; 8 (Suppl 5): 1-7.
8. Bousser MG, Roberts RS, Gent M. Ticlopidine and clopidogrel in secondary stroke prevention. Cerebrovasc Dis 1997; 7 (Suppl 6): 17-23.
9. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, et al, and The CATS Group. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989; I: 1215-20.
10. Hass WK, Easton DJ, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321: 501-7.
11. Davis SM, Donnan GA. Secondary prevention for stroke after CAPRIE and ESPS-2. Cerebrovasc Dis 1998; 8: 73-5.
12. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
13. Harker LA. Therapeutic inhibition of platelet function in stroke. Cerebrovasc Dis 1998; 8 (Suppl 5): 8-18.
14. Bousser MG, Eschwege E, Haguenau M, Lefaucconnier JM, Thibult N, Touboul D, et al. 'AICLA' controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983; 14: 5-14.
15. The American-Canadian Co-Operative Study Group. Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoints results. Stroke 1985; 16: 406-15.
16. Diener HC. Dipyridamole trials in stroke prevention. Neurology 1998; 51 (Suppl 3): S17-9.
17. ESPS Group. European Stroke Prevention Study. Stroke 1990; 21: 1122-30.
18. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13.
19. Dyken ML. Secondary prevention for stroke after CAPRIE and ESPS-2. Cerebrovasc Dis 1998; 8: 75-7.
20. Tijssen JGP. Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole. A review of clinical trial results. Neurology 1998; 51 (Suppl 3): S15-6.
21. Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-9.